Insider · CIK 0001777760
Andrew Craig Miller
Files at KYTX (Kyverna Therapeutics, Inc.), ANRO (Alto Neuroscience, Inc.). First filing -, latest -.
In brief
Andrew Craig Miller files SEC Form 4 as director at KYTX (Kyverna Therapeutics, Inc.), and also at ANRO (Alto Neuroscience, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew Craig Miller has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | ANRO Alto Neuroscience, Inc. | AGrant or award Stock Option (right to buy)derivative | +26,000 | $0.00 | $0 | 26,000 | May 29, 2026 |
| Feb 24, 2026 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +11,006 | $0.00 | $0 | 11,006 | Mar 4, 2026 |
| Feb 24, 2026 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,945 | $0.00 | $0 | 42,945 | Mar 4, 2026 |
Questions about Andrew Craig Miller
Answered from the filings on this page, as of the latest one.
Is Andrew Craig Miller buying or selling?
Andrew Craig Miller has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew Craig Miller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Craig Miller has 0.
Where does Andrew Craig Miller file Form 4?
Andrew Craig Miller has filed Form 4 at KYTX (Kyverna Therapeutics, Inc.); ANRO (Alto Neuroscience, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.